Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older
Clinical trial NCT05153317 · COMPLETED
Trial details
- NCT number
- NCT05153317
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-17
- Primary completion
- 2026-01-29
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.